-
FORMULARY EXCLUSIONS AND NON-ADHERENCE TO DISEASE-MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS IN MEDICARE PART D
Mar 18, 2026, 21:38 PM -
THE IMPACT OF THE FIRST FAMILY CORONAVIRUS RESPONSE ACT ON HEALTHCARE SERVICE UTILIZATION AMONG MEDICAID BENEFICIARIES WITH SICKLE CELL DISEASE IN WISCONSIN
Mar 18, 2026, 21:38 PM -
EVALUATING INITIAL MEDICATION ADHERENCE THRESHOLDS AS PREDICTORS OF CONTINUATION ADHERENCE AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A CLAIMS-BASED ANALYSIS
Mar 18, 2026, 21:38 PM -
MEAN OVERALL SURVIVAL FROM THE PHASE 3 MIRASOL TRIAL OF MIRVETUXIMAB SORAVTANSINE VS INVESTIGATOR’S CHOICE OF CHEMOTHERAPY IN WOMEN WITH FR?-HIGH PLATINUM-RESISTANT OVARIAN CANCER (GOG 3045/ENGOT-OV55; NCT04209855)
Mar 18, 2026, 21:38 PM -
INFLUENCING FACTORS ON THE APPROVAL LAG FOR INNOVATIVE DRUGS IN CHINA
Mar 18, 2026, 21:38 PM -
TARGET POPULATION SIZE AND LAUNCH PRICE DYNAMICS OF CELL AND GENE THERAPIES (CGTS)
Mar 18, 2026, 21:38 PM -
INDIVIDUAL PREFERENCES FOR UPPER EXTREMITY PROSTHETICS ALONG A USER-COMPLEXITY FRAMEWORK: A DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
IMPACT OF COVID-19 PANDEMIC ON HEALTHCARE UTILIZATION IN THE US AS OBSERVED IN FEDERATED ELECTRONIC HEALTH RECORDS: 2016 TO 2022
Mar 18, 2026, 21:38 PM -
IMPACT AND COST-EFFECTIVENESS OF DOXYCYCLINE POST-EXPOSURE PROPHYLAXIS IN AUSTRALIAN MEN WHO HAVE SEX WITH MEN
Mar 18, 2026, 21:38 PM -
WHAT'S IN AN ABSTRACT? PICOS REPORTING FREQUENCIES TO INFORM AI-ASSISTED SCREENING
Mar 18, 2026, 21:38 PM -
EXPLORING PHYSICIANS’ PERSPECTIVES ON BARRIERS TO ENGAGING PATIENTS WITH RARE DISEASES AND/OR THEIR CAREGIVERS IN SHARED DECISION-MAKING IN THE UNITED STATES (US): FINDINGS FROM A CROSS-SECTIONAL SURVEY
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE PATIENTS WITH FIBROMYALGIA: A US REAL-WORLD CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
FROM RETRIEVAL TO VERDICT: A HYBRID LLM PIPELINE FOR EVALUATING MEDICAL AND ECONOMIC CLAIMS
Mar 18, 2026, 21:38 PM -
A MODULAR ONCOLOGY REFERENCE MODEL FOR EARLY ECONOMIC EVALUATION: A CASE STUDY IN EGFR-MUTATED NSCLC
Mar 18, 2026, 21:38 PM -
DEFINING TREATMENT TOLERABILITY FROM THE PATIENT’S PERSPECTIVE: A MIXED-METHODS ANALYSIS OF THE CANCER EXPERIENCE REGISTRY
Mar 18, 2026, 21:38 PM -
REAL-WORLD SURVIVAL AND PREDICTORS OF MORTALITY IN HEMATOLOGIC MALIGNANCIES DURING AN ERA OF THERAPEUTIC ADVANCEMENT AND HEALTHCARE DISRUPTION: A POPULATION-BASED SEER STUDY
Mar 18, 2026, 21:38 PM -
METHODOLOGICAL CHARACTERISTICS OF PHARMACOGENOMICS-INTEGRATED AI CLINICAL DECISION SUPPORT SYSTEMS (AI-CDSS): A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
MANAGING LIMITATIONS OF NET PRICE ESTIMATES AT LAUNCH
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF RSV MATERNAL IMMUNIZATION [RSVPREF] IN THE DOMINICAN REPUBLIC: A COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN PINEAL NEOPLASM AND ALZHEIMER’S DISEASE PROGRESSION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A POPULATION-BASED COHORT STUDY
Mar 18, 2026, 21:38 PM
